CareDx to Announce Third Quarter 2019 Financial Results on October 31st, 2019

BRISBANE, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. CDNA, a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that it will release financial results for the third quarter 2019 after the market closes on Thursday, October 31^st, 2019. Peter Maag, Chief Executive Officer, and Michael Bell, Chief Financial Officer, will host a conference call to review the Company's results beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing 1-877-705-6003 for domestic callers or 1-201-493-6725 for international callers.  Please reference Conference ID: 13695374.  To listen to a live webcast, please visit the investor relations section of CareDx's website at: www.CareDx.com.

A replay of the call will be available beginning October 31^st, 2019 at 4:30pm PT/7:30pm ET through 4:30pm PT/7:30pm ET on November 14^th, 2019.  To access the replay, dial 1-844-512-2921 or 1-412-317-6671 and reference Conference ID: 13695374.  The webcast will also be available on CareDx's website for one year following the completion of the call.

About CareDx

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.

For more information, please visit: www.CareDx.com.

CONTACTS:

Michael Bell

Chief Financial Officer, CareDx Inc.

415-287-2324

mbell@caredx.com